SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: HoodBuilder who wrote (1038)11/19/1998 6:11:00 PM
From: Winegrower  Read Replies (1) | Respond to of 1580
 
Some analyist a few weeks ago, I don't remmember who, gave a target price for merck of 165 for 12 months. I hope they annouce a split at 160 or so driving the price up more. I've owned this since 92 and will not sell until the company falters if ever. A split will bring in more investors and triple our money again in a few years.



To: HoodBuilder who wrote (1038)11/20/1998 5:34:00 AM
From: David C. Burns  Read Replies (2) | Respond to of 1580
 
Couldn't they announce the split subject to shareholder approval?

Yes, generally that is how it's done. However, they aren't going to put it to a special vote -- it's too expensive to prepare the materials, mailings, etc. So the timing, it seems to me, is obviously going to be closer to the annual meeting where it can be acted on in the regular course of business.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News